Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

October 28, 2014 updated by: Johnson & Johnson Vision Care, Inc.

The Clinical Performance of the Silicone Hydrogel Contact Lens on Low to Moderate Astigmatism in Japan

This study seeks to evaluate the clinical performance of a recently released contact lens designed to correct astigmatism to an established contact lens that has historically been used in these patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fukushima
      • Fukushimashi, Fukushima, Japan
        • Shioya eye clinic
    • Kanagawa
      • Odawarashi, Kanagawa, Japan
        • Takahashi Eye Clinic
    • Kyoto
      • Jyoyoshi, Kyoto, Japan
        • Kodama Eye Clinic
    • Osaka
      • Osakashi, Osaka, Japan
        • Inaba eye clinic
      • Osakashi, Osaka, Japan
        • Iwasaki Eye Clinic
      • Osakashi, Osaka, Japan
        • Watanabe Eye Clinic
    • Shizuoka
      • Shizuokashi, Shizuoka, Japan
        • Sakura eye clinic
    • Tokyo
      • Minatoku, Tokyo, Japan
        • Kajita eye clinic
      • Shibuyaku, Tokyo, Japan
        • Dogenzakaitoi eye clinic
    • Yamaguchi
      • Shimonosekishi, Yamaguchi, Japan
        • Ueda Eye Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The subject is 18 to 39 years of age. (Parental consent is required for a minor child i.e. under the age of 20.)
  2. The subject has signed an informed consent with his/her own judgement for participation in the study.
  3. The subject currently is a habitual wearer of spherical or toric daily-wear soft contact lenses, excluding daily disposables, in daily wear bases.

Exclusion Criteria:

  1. The subject has any ocular or systemic allergies that interfere with contact lens wear.
  2. The subject has dry eye and lacrimal apparatus disease that could interfere with contact lens wear.
  3. The subject has any systemic disease or autoimmune disease that interferes with contact lens wear.
  4. The subject has corneal edema, neovascularization, corneal staining or other ocular abnormalities (Grade 3 or above) that clinically apparently interfere with contact lens wear.
  5. The subject has any anterior segment eye disease (palpebral abnormalities, corneal hypesthesia, corneal epithelial defect, bulbar conjunctival hyperemia, etc.) that clinically apparently interferes with contact lens wear.
  6. The subject has a history of solution reactions to the chemical cleaner/disinfectant to be used in this study, as far as known to the subject.
  7. The subject has ocular infection.
  8. The subject has ocular inflammation (including acute/subacute anterior segment inflammations and uveitis).
  9. The subject has corneal distortion resulting from previous experience of hard contact lens wear.
  10. The subject has infectious disease (pneumonia, tuberculosis, etc.) or immunosuppressive disease (HIV positive etc.), as far as known to the subject.
  11. The subject has diabetes, as far as known to the subject.
  12. The subject is pregnant or in the lactation period, as far as known to the subject.
  13. The subject uses any eye remedies (excluding artificial tear substitutes or hyaluronic acid drops for reducing dryness while wearing contact lenses).
  14. The subject had any ocular trauma or surgery within 8 weeks prior to participation in the study.
  15. The subject is a wearer of hard contact lenses (including rigid gas permeable).
  16. The subject is exposed to a dry environment on a constant basis.
  17. The subject is exposed to a living environment where dust, chemicals, etc. can easily enter the eye.
  18. The subject is unable to follow the principal investigator's instructions.
  19. The subject is unable to follow lens hygiene procedures necessary for contact lens wear.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: spherical contact lens
Subjects will wear and evaluate a spherical soft contact lens daily for 2 weeks
contact lens
Other Names:
  • ACUVUE OASYS
Experimental: toric contact lens
Subjects will wear and evaluate a toric soft contact lens daily for 2 weeks
contact lens
Other Names:
  • ACUVUE OASYS for Astigmatism

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject-reported satisfaction for vision
Time Frame: After 2 weeks of lens wear
Scale of 0 to 100, were 0=extremely poor and 100=Excellent
After 2 weeks of lens wear
Subject-reported satisfaction for comfort.
Time Frame: After 2 weeks of lens wear
Scale of 0 to 100, were 0=extremely poor and 100=Excellent
After 2 weeks of lens wear

Secondary Outcome Measures

Outcome Measure
Time Frame
Subject preference for lens type.
Time Frame: After 2 weeks of lens wear.
After 2 weeks of lens wear.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2008

Primary Completion (Actual)

June 1, 2008

Study Registration Dates

First Submitted

March 14, 2008

First Submitted That Met QC Criteria

March 14, 2008

First Posted (Estimate)

March 20, 2008

Study Record Updates

Last Update Posted (Estimate)

October 29, 2014

Last Update Submitted That Met QC Criteria

October 28, 2014

Last Verified

October 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CR-0804

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Error

Clinical Trials on senofilcon A sphere soft contact lens

3
Subscribe